Overview

Carperitide in Acute Respiratory Distress Syndrome (ARDS)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).
Phase:
Phase 2
Details
Lead Sponsor:
Suntory Pharmaceutical
Treatments:
Cardiodilatin